期刊论文详细信息
Journal for ImmunoTherapy of Cancer | |
Target discovery for T cell therapy: next steps to advance Immunotherapies | |
Kai W Wucherpfennig1,10  Paul F Robbins6  Carlos A Ramos5  Laszlo Radvanyi4  Yoav Peretz1,11  Richard Morgan9  Achim A Jungbluth1,12  Emma Hickman7  Stanley R Frankel8  Zelig Eshhar3  Joanna E Brewer2  Adrian Bot1  | |
[1] Translational Medicine, Kite Pharma Inc., 2225 Colorado Avenue, Santa Monica, 90404, CA, USA;Cellular Biology, Adaptimmune Ltd., Abingdon, UK;Immunology, The Weizmann Institute of Science, Rehovot, Israel;Lion Biotechnologies, Woodland Hills, CA, USA;Medicine, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA;DNA Sequencing and FACS Cores, Surgery Branch; Staff Scientist, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA;Target Validation, Immunocore, Abingdon, UK;Oncology Early Development, Therapeutic Area Head, Amgen, Thousand Oaks, CA, USA;Immunotherapy, Bluebird Bio, Boston, MA, USA;Cancer Immunology & AIDS, Dana-Farber Cancer Institute; Professor of Neurology at Harvard Medical School, Cambridge, MA, USA;Immunology, ImmuneCarta, Caprion, Montreal, Quebec, Canada;Immunohistochemistry, Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA | |
关键词: Vaccines; Antibodies; Adoptive T cell therapy; Targets; Tumor infiltrating lymphocytes; T cell receptors; Chimeric antigen receptors; Adoptive T cell therapy; Immunotherapy; | |
Others : 1221147 DOI : 10.1186/s40425-015-0061-5 |
|
received in 2015-03-02, accepted in 2015-03-25, 发布年份 2015 | |
【 摘 要 】
Investigators from academia and industry gathered on August 14, 2014, in Boston at the Inaugural ImVacS conference entitled “Target Discovery for T Cell Therapy: Next Step to Advance Immunotherapies”. Novel targets, discovery strategies and enabling technologies were presented and discussed.
【 授权许可】
2015 Bot et al.; licensee BioMed Central.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20150727093346648.pdf | 721KB | download |